Joseph F Mort
Overview
Explore the profile of Joseph F Mort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mort J, Brighton D, DiBenedetto S, Wells L, Clark S, Reid J, et al.
Eur J Haematol
. 2024 Nov;
114(3):481-494.
PMID: 39601208
Gemtuzumab ozogamicin (GO) is a CD33-targeting antibody-drug conjugate approved for the treatment of CD33-positive de novo and relapsed and refractory acute myeloid leukemia (AML). Subset analyses have demonstrated improved clinical...
2.
Mort J, Tran D, Dougherty S, Zielinski R, Williams M, Davidson K
Case Rep Hematol
. 2023 Jun;
2023:9714457.
PMID: 37388486
Immune thrombocytopenia (ITP) is an acquired thrombocytopenia resulting from immune-mediated platelet destruction via antiplatelet antibodies and T cells. Medical management of ITP includes corticosteroids and multiple other adjunct therapies, with...
3.
Mort J, Davis J, Mahoro G, Stotts M, Intagliata N, Northup P
Clin Gastroenterol Hepatol
. 2020 Aug;
19(7):1436-1442.
PMID: 32777555
Background & Aims: Studies of the effects of direct oral anticoagulants (DOACs) in patients with cirrhosis have been limited by their small sample size, inclusion of patients with well-compensated cirrhosis,...
4.
Mort M, Sen J, Morris A, DeGregory K, McLoughlin E, Mort J, et al.
J Oncol Pharm Pract
. 2019 Sep;
26(3):680-687.
PMID: 31500517
Background: Acute myeloid leukemia patients receive anthracycline-containing induction chemotherapy. Anthracyclines cause cardiotoxicity; however, there is a paucity of data reflecting the risk of cardiotoxicity in the acute myeloid leukemia population,...